Nurami is committed to enhance healing and boost recovery in patients following surgeries, through innovation and soft tissue repair technology
ARTIFASCIA® DURAL GRAFT Shows Positive Results IN Clinical Trial
Nurami Medical’s ArtiFascia® is a surgical patch for healing the Dura after neurosurgeries, and is the first nanofiber-based patch that combines two functions. Firstly, its porous nanofiber structure provides a scaffold which helps Dura regeneration and faster healing. Secondly, the patch is integrated with a temperature-sensitive, viscoelastic, non-porous barrier film that helps prevent CSF leakage and eliminate the need to apply a liquid sealant during surgery. In a multi-center clinical trial of 85 patients, ArtiFascia® successfully achieved all endpoints, preventing leakages and showing non-inferiority to the tested commercially available alternatives.
*For investigational use only
NOVAFIBREX™ SURGICAL ADHESIVE SEALANT
NovaFibreX synthetic surgical adhesive and sealant is designed for healing of the digestive system after surgery. Internal leakage leads to poor recovery and is common in up to 30% of cases (for example, bariatric, hepato-biliary and pancreatic). Complications include infection, sepsis and abscesses, which lead to prolonged hospitalization and mortality rates of up to 3%. NovaFibreX™ is designed to withstand the harsh conditions that prevent rapid healing of the digestive system after surgery and will help reduce complications.
*For investigational use only
ARTIFIXTM Innovative suture-less adhesive patch
ArtiFixTM is comprised of electrospun fibers and a safe tissue adhesive polymer. The fibers sre desgined to provide a scaffold for a rapid tissue regeneration while the adhesive polymer helps ensure robust tissue adhesion until tissue recovery is achieved. ArtiFixTM will be used as a Dural graft or a general soft tissue repair patch. ArtiFixTM will soon enter preclinical trials.
*For investigational use only
NURAMI MEDICAL
IS AT THE
FOREFRONT
OF NEXT
GENERATION
SURGERY
GENERATION
SURGERY
Founded in 2014 by experts in nanofibers and biomaterials, Dr. Amir Bahar and Nora Nseir, Nurami Medical is a clinical stage medical device company. The company develops innovative patches and sealants that are based on nanofibers and advanced materials to improve patient outcomes and enhance recovery after surgery.
The company’s first product, ArtiFascia®, is an innovative nanofiber-based patch for Dural repair after neurosurgeries. The patch combines a non-porous barrier film designed to prevent CSF leakage with a porous scaffold, in a sandwich-like fomat, to help enhance regeneration and Dural healing. ArtiFascia® targets the $850M Dural repair market, which is poised to reach $1.4B in 2025.
Our vision is to revolutionize the field of regenerative medicine by developing application-specific patches and surgical sealants, using unique combinations of nanofibers and functional biomaterials.
Our vision is to revolutionize the field of regenerative medicine by developing application-specific patches and surgical sealants, using unique combinations of nanofibers and functional biomaterials.
ADVANTAGES
Nurami Medical utilizes novel formulations of nanofibers and advanced materials to revolutionize patient healing and recovery after surgery
